Cargando…

Fu’s subcutaneous needling as an adjunctive therapy for diaphragmatic dysfunction in a critically ill patient with severe neurologic disability: A case report

RATIONALE: Diaphragmatic dysfunction is prevalent among intensive care unit patients. The use of Fu’s subcutaneous needling (FSN) for respiratory problems is a new issue and few study has been conducted so far. PATIENT CONCERNS: Despite conventional treatments, the patient continued using noninvasiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hu, Yang, Cong Cong, Bai, Tianyu, Sun, Jian, Fu, Zhonghua, Chou, Li-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627591/
https://www.ncbi.nlm.nih.gov/pubmed/37933049
http://dx.doi.org/10.1097/MD.0000000000035550
_version_ 1785131554339553280
author Li, Hu
Yang, Cong Cong
Bai, Tianyu
Sun, Jian
Fu, Zhonghua
Chou, Li-Wei
author_facet Li, Hu
Yang, Cong Cong
Bai, Tianyu
Sun, Jian
Fu, Zhonghua
Chou, Li-Wei
author_sort Li, Hu
collection PubMed
description RATIONALE: Diaphragmatic dysfunction is prevalent among intensive care unit patients. The use of Fu’s subcutaneous needling (FSN) for respiratory problems is a new issue and few study has been conducted so far. PATIENT CONCERNS: Despite conventional treatments, the patient continued using noninvasive ventilation after discharge from the intensive care unit due to diaphragmatic dysfunction. DIAGNOSIS: Diaphragmatic dysfunction. INTERVENTIONS: After the myofascial trigger points were confirmed in the neck, chest, and abdomen area, FSN therapy was performed using disposable FSN needles. FSN needles were penetrated into the subcutaneous layer. OUTCOMES: The patient dyspnea and tachypnea improved, and noninvasive ventilation time dropped significantly. The patient was successfully weaned from the ventilator after 3 sessions of FSN therapy, and there was an increase in diaphragmatic excursion and tidal fraction of the diaphragm via the ultrasound imaging. We found no evidence of relapse 12 months after treatment. LESSONS: FSN therapy has potential as an alternative strategy for patients with diaphragmatic dysfunction and severe neurologic disabilities who do not respond well to conventional therapies, but further research is still required to establish the effects of FSN on diaphragmatic function.
format Online
Article
Text
id pubmed-10627591
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-106275912023-11-07 Fu’s subcutaneous needling as an adjunctive therapy for diaphragmatic dysfunction in a critically ill patient with severe neurologic disability: A case report Li, Hu Yang, Cong Cong Bai, Tianyu Sun, Jian Fu, Zhonghua Chou, Li-Wei Medicine (Baltimore) 3800 RATIONALE: Diaphragmatic dysfunction is prevalent among intensive care unit patients. The use of Fu’s subcutaneous needling (FSN) for respiratory problems is a new issue and few study has been conducted so far. PATIENT CONCERNS: Despite conventional treatments, the patient continued using noninvasive ventilation after discharge from the intensive care unit due to diaphragmatic dysfunction. DIAGNOSIS: Diaphragmatic dysfunction. INTERVENTIONS: After the myofascial trigger points were confirmed in the neck, chest, and abdomen area, FSN therapy was performed using disposable FSN needles. FSN needles were penetrated into the subcutaneous layer. OUTCOMES: The patient dyspnea and tachypnea improved, and noninvasive ventilation time dropped significantly. The patient was successfully weaned from the ventilator after 3 sessions of FSN therapy, and there was an increase in diaphragmatic excursion and tidal fraction of the diaphragm via the ultrasound imaging. We found no evidence of relapse 12 months after treatment. LESSONS: FSN therapy has potential as an alternative strategy for patients with diaphragmatic dysfunction and severe neurologic disabilities who do not respond well to conventional therapies, but further research is still required to establish the effects of FSN on diaphragmatic function. Lippincott Williams & Wilkins 2023-11-03 /pmc/articles/PMC10627591/ /pubmed/37933049 http://dx.doi.org/10.1097/MD.0000000000035550 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 3800
Li, Hu
Yang, Cong Cong
Bai, Tianyu
Sun, Jian
Fu, Zhonghua
Chou, Li-Wei
Fu’s subcutaneous needling as an adjunctive therapy for diaphragmatic dysfunction in a critically ill patient with severe neurologic disability: A case report
title Fu’s subcutaneous needling as an adjunctive therapy for diaphragmatic dysfunction in a critically ill patient with severe neurologic disability: A case report
title_full Fu’s subcutaneous needling as an adjunctive therapy for diaphragmatic dysfunction in a critically ill patient with severe neurologic disability: A case report
title_fullStr Fu’s subcutaneous needling as an adjunctive therapy for diaphragmatic dysfunction in a critically ill patient with severe neurologic disability: A case report
title_full_unstemmed Fu’s subcutaneous needling as an adjunctive therapy for diaphragmatic dysfunction in a critically ill patient with severe neurologic disability: A case report
title_short Fu’s subcutaneous needling as an adjunctive therapy for diaphragmatic dysfunction in a critically ill patient with severe neurologic disability: A case report
title_sort fu’s subcutaneous needling as an adjunctive therapy for diaphragmatic dysfunction in a critically ill patient with severe neurologic disability: a case report
topic 3800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627591/
https://www.ncbi.nlm.nih.gov/pubmed/37933049
http://dx.doi.org/10.1097/MD.0000000000035550
work_keys_str_mv AT lihu fussubcutaneousneedlingasanadjunctivetherapyfordiaphragmaticdysfunctioninacriticallyillpatientwithsevereneurologicdisabilityacasereport
AT yangcongcong fussubcutaneousneedlingasanadjunctivetherapyfordiaphragmaticdysfunctioninacriticallyillpatientwithsevereneurologicdisabilityacasereport
AT baitianyu fussubcutaneousneedlingasanadjunctivetherapyfordiaphragmaticdysfunctioninacriticallyillpatientwithsevereneurologicdisabilityacasereport
AT sunjian fussubcutaneousneedlingasanadjunctivetherapyfordiaphragmaticdysfunctioninacriticallyillpatientwithsevereneurologicdisabilityacasereport
AT fuzhonghua fussubcutaneousneedlingasanadjunctivetherapyfordiaphragmaticdysfunctioninacriticallyillpatientwithsevereneurologicdisabilityacasereport
AT chouliwei fussubcutaneousneedlingasanadjunctivetherapyfordiaphragmaticdysfunctioninacriticallyillpatientwithsevereneurologicdisabilityacasereport